LUPIN and EQLUPIN Related Headlines
Go Back- Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans
- Lupin Launches Topiramate Extended-Release Capsules in the United States
- Lupin gets FDA approval for risperidone injection with exclusivity
- Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform
LUPIN and EQLUPIN Related Press Releases
Go Back- Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans
- Lupin Launches Topiramate Extended-Release Capsules in the United States
- Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform
